|Bid||1,520.00 x 175400|
|Ask||1,582.50 x 417900|
|Day's Range||1,517.00 - 1,540.50|
|52 Week Range||1,446.50 - 1,745.56|
|PE Ratio (TTM)||44.90|
|Dividend & Yield||1.00 (4.84%)|
|1y Target Est||N/A|
Q2 2017 GlaxoSmithKline PLC Earnings Call
Rating Action: Moody's changes outlook on GSK's A2 rating to stable from negative; affirms ratings. Global Credit Research- 27 Jul 2017. London, 27 July 2017-- Moody's Investors Service has today changed ...
Both in-house and M&A solutions will be risky and take time to bear fruit.